Marketwired - Maxim Group LLC has announced the enhancement of its investment banking platform through the promotion of Eric Cheng to Senior Managing Director and Head of Healthcare Investment Banking and the appointments of John Shaw III and John Fletcher as Managing Directors.
'Eric has been successful in leveraging his wealth of transaction experience, depth of industry knowledge and extensive relationships in the healthcare sector to deliver Maxim's full suite of investment banking capabilities and has created significant value for our clients. We are pleased to acknowledge his contributions to Maxim Group and his leadership skills in the healthcare space', said Cliff Teller, Executive Managing Director and Head of Investment Banking.
Cheng joined Maxim Group in August 2011. He has over 16 years of investment banking experience and has completed over 80 equity, debt and M&A transactions, representing over $7.7 billion in aggregate value. He is focused on the healthcare sector and has advised and raised capital for a wide range of biotechnology, specialty pharmaceutical, medical device and healthcare services companies.
Teller also added, 'We are very pleased to welcome John Shaw and John Fletcher to our growing Investment Banking practice. Their experience, skills and relationships will enable them to make a significant contribution as we continue to expand our business and gain market share globally'.
Shaw has over 21 years of investment banking and securities industry experience. He is an accomplished investment banker and entrepreneur who has advised and raised public and private capital for acquisition vehicles and growth companies across multiple industries in the U.S., Europe and Asia.
Prior to joining Maxim Group, Shaw was a senior officer in equity capital markets at Deutsche Bank from 2007-2012 where he was responsible for managing the bank's special purpose acquisition company practice globally. While at Deutsche Bank, he led the origination and execution of SPAC IPOs raising $3.2b of gross proceeds and the execution of successful business combinations in transactions with an aggregate enterprise value of over $7b.
Prior to Deutsche Bank, Shaw co-founded the boutique investment bank Legend Merchant Group, which he led as President and co-Chairman from 2002-2007. In his role at Legend, Shaw drove the growth of the firm from 5 to over 50 professionals and built its advisory and capital markets practices, which led or co-managed over 50 financing transactions ranging in size from $2m to $375m.
Fletcher has over 17 years of investment banking experience. Prior to joining Maxim Group, he spent more than 17 years at Brean Capital, LLC, most recently as a Managing Director and co-head of Investment Banking with a focus on Oil and Gas companies. Fletcher has completed a vast array of transactions across different product types including IPOs, Secondaries/ Follow-on Offerings, SPACs, Registered Directs, CMPOs, PIPEs, Privates, Fairness Opinions and M&A mandates.
His public offering transactional experience spans a broad range of industries having raised in excess of $4.5 billion. Fletcher has transacted with companies in numerous industries including Oil and Gas, Healthcare, Financial Services, Technology, Consumer and China.
Fletcher began his career at Deloitte & Touche, LLP, and received his BA as well as an MBA from Wilkes University.